<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Renin-angiotensin-<z:chebi fb="0" ids="27584,30834">aldosterone</z:chebi> system inhibitors prevent the progression of <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e> in patients with diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo>, and we studied how that benefit varies by the type of <z:mp ids='MP_0002055'>diabetes</z:mp> and baseline urinary albumin </plain></SENT>
<SENT sid="1" pm="."><plain>We pooled data from 49 randomized controlled trials in a meta-analysis using the ratio of endpoint urinary albumin levels in those treated compared to those untreated with renin-angiotensin-<z:chebi fb="0" ids="27584,30834">aldosterone</z:chebi> system inhibitors in both fixed- and random-effects models </plain></SENT>
<SENT sid="2" pm="."><plain>The urinary albumin excretion for treated microalbuminuric patients with Type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> was on average 60% lower at the end of the trial compared with patients not treated with renin-angiotensin-<z:chebi fb="0" ids="27584,30834">aldosterone</z:chebi> system inhibitors using the fixed-effects model and 67% lower using the random-effects model </plain></SENT>
<SENT sid="3" pm="."><plain>There was no significant effect of treatment in patients with <z:mpath ids='MPATH_458'>normal</z:mpath> albumin excretion </plain></SENT>
<SENT sid="4" pm="."><plain>For normoalbuminuric patients with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, urinary albumin excretion was on average 12% lower after treatment using the fixed-effects model compared to 21% lower using the random-effects model </plain></SENT>
<SENT sid="5" pm="."><plain>For microalbuminuric patients, urinary albumin excretion was on average 23% lower using the fixed-effects model and 27% lower using the random-effects model </plain></SENT>
<SENT sid="6" pm="."><plain>Thus, renin-angiotensin-<z:chebi fb="0" ids="27584,30834">aldosterone</z:chebi> system inhibition reduced urinary albumin excretion for Type 1 diabetic patients with micro-, but not those with normoalbuminuria </plain></SENT>
<SENT sid="7" pm="."><plain>Treatment reduced urinary albumin excretion for Type 2 diabetic patients with and without <z:mp ids='MP_0002959'>microalbuminuria</z:mp> </plain></SENT>
</text></document>